[ad_1]
Stockholders’ Rights Law Firm Robbins Law Firm Is investigating Generation Bio Co. (Nasdaq stock code:GBIO) To determine whether certain executives and directors of Generation Bio violated the Securities Exchange Act of 1934 and violated their fiduciary obligations to shareholders. Generation Bio develops gene therapies for the treatment of rare and epidemic diseases.
If you want to learn more about our investigation into Generation Bio Co.’s misconduct, please click here.
Generation Bio Co. (GBIO) reports poor results of preclinical studies of the hemophilia A project
On December 14, 2021, Generation Bio issued a press release, “Providing the latest information on the expression of factor VIII in a series of mouse and companion non-human primate (NHP) studies on hemophilia A, As…
The full story on Benzinga.com
[ad_2]
Source link
